Simplex Trading’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,498
| Closed | -$10.6K | – | 9294 |
|
|
2024
Q2 | $11K | Buy |
3,498
+2,551
| +269% | +$11.2K | ﹤0.01% | 7375 |
|
|
2024
Q1 | $5K | Sell |
947
-4,858
| -84% | -$26.2K | ﹤0.01% | 8027 |
|
|
2023
Q4 | $25K | Buy |
5,805
+5,048
| +667% | +$16.7K | ﹤0.01% | 6742 |
|
|
2023
Q3 | $1K | Sell |
757
-4,593
| -86% | -$15.6K | ﹤0.01% | 8390 |
|
|
2023
Q2 | $18K | Sell |
5,350
-5,017
| -48% | -$15.7K | ﹤0.01% | 6886 |
|
|
2023
Q1 | $32K | Buy |
+10,367
| New | +$39.1K | ﹤0.01% | 6428 |
|
|
2022
Q4 | – | Sell |
-15,946
| Closed | -$55K | – | 10105 |
|
|
2022
Q3 | $37K | Buy |
15,946
+12,483
| +360% | +$36.5K | ﹤0.01% | 6820 |
|
|
2022
Q2 | $9K | Buy |
+3,463
| New | +$8.61K | ﹤0.01% | 8382 |
|
|
2022
Q1 | – | Sell |
-78,512
| Closed | -$203K | – | 11138 |
|
|
2021
Q4 | $238K | Buy |
78,512
+75,870
| +2,872% | +$329K | ﹤0.01% | 4922 |
|
|
2021
Q3 | $24K | Hold |
2,642
| – | – | ﹤0.01% | 8278 |
|
|
2021
Q2 | $24K | Buy |
+2,642
| New | +$26.8K | ﹤0.01% | 8434 |
|
|
2020
Q2 | – | Sell |
-14,039
| Closed | -$145K | – | 8151 |
|
|
2020
Q1 | $118K | Sell |
14,039
-57,611
| -80% | -$560K | ﹤0.01% | 4194 |
|
|
2019
Q4 | $626K | Buy |
71,650
+68,243
| +2,003% | +$565K | ﹤0.01% | 2529 |
|
|
2019
Q3 | $36K | Sell |
3,407
-9,716
| -74% | -$105K | ﹤0.01% | 5330 |
|
|
2019
Q2 | $166K | Buy |
13,123
+5,092
| +63% | +$117K | ﹤0.01% | 3662 |
|
|
2019
Q1 | $311K | Sell |
8,031
-26,685
| -77% | -$815K | ﹤0.01% | 3158 |
|
|
2018
Q4 | $706K | Buy |
34,716
+28,084
| +423% | +$843K | ﹤0.01% | 1923 |
|
|
2018
Q3 | $304K | Sell |
6,632
-11,997
| -64% | -$578K | ﹤0.01% | 3166 |
|
|
2018
Q2 | $1.1M | Buy |
+18,629
| New | +$1.08M | ﹤0.01% | 1706 |
|
|
2018
Q1 | – | Sell |
-3,395
| Closed | -$254K | – | 6675 |
|
|
2017
Q4 | $335K | Buy |
+3,395
| New | +$380K | 0.01% | 934 |
|
|
2017
Q3 | – | Sell |
-14,757
| Closed | -$1.37M | – | 6438 |
|
|
2017
Q2 | $1.29M | Buy |
14,757
+9,166
| +164% | +$513K | 0.06% | 280 |
|
|
2017
Q1 | $207K | Buy |
+5,591
| New | +$204K | 0.01% | 1191 |
|
|
2016
Q4 | – | Sell |
-16,918
| Closed | -$732K | – | 6342 |
|
|
2016
Q3 | $1.13M | Buy |
16,918
+8,770
| +108% | +$443K | 0.08% | 223 |
|
|
2016
Q2 | $242K | Sell |
8,148
-4,410
| -35% | -$138K | 0.02% | 894 |
|
|
2016
Q1 | $368K | Buy |
12,558
+567
| +5% | +$25.6K | 0.03% | 570 |
|
|
2015
Q4 | $940K | Buy |
11,991
+2,181
| +22% | +$171K | 0.07% | 233 |
|
|
2015
Q3 | $739K | Buy |
9,810
+4,996
| +104% | +$472K | 0.05% | 315 |
|
|
2015
Q2 | $562K | Buy |
4,814
+3,110
| +183% | +$563K | 0.05% | 361 |
|
|
2015
Q1 | $402K | Buy |
1,704
+595
| +54% | +$127K | 0.05% | 391 |
|
|
2014
Q4 | $210K | Buy |
+1,109
| New | +$246K | 0.03% | 579 |
|
Other funds holding PBYI
ACA
VCM
VPM
Simplex Trading's PBYI Position: Q3 2024 in Review
Simplex Trading sold out of Puma Biotechnology (PBYI) in Q3 2024, closing a stake of 3,498 shares — an estimated $10.6K sold.
Simplex Trading first reported a position in PBYI in Q4 2014 and held it in 30 quarters. The position peaked at $1.29M in Q2 2017. 100 funds tracked by Wall St. Rank hold PBYI as of Q3 2024.
- Simplex Trading reported no remaining Puma Biotechnology position as of Q3 2024 after selling out during the quarter.
- Simplex Trading sold 3,498 Puma Biotechnology shares in Q3 2024, an estimated $10.6K.
- Simplex Trading first reported a position in Puma Biotechnology in Q4 2014 and held it in 30 quarters.
- Simplex Trading's Puma Biotechnology position peaked at $1.29M in Q2 2017.
- 100 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2024.
Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.